【摘要】 自2019年新型冠状病毒感染(COVID-19)疫情的大流行以来，对全球药学工作场景和从业人员、工作方式和业务范围等带来许多巨大改变和影响，其中众多的改变都事关全球未来药学的发展和卫生政策的调整。国际药学联合会(FIP)一直关注COVID-19大流行对药学领域的改变，对新兴的趋势进行分析，洞察其中的机遇，共同应对将要面对的挑战。该文梳理了FIP就COVID-19大流行所做的趋势分析，结合我国国情，从药学实践、药学科研和药学教育领域等方面对全球药学发展与变化趋势进行讨论和研判，以期应对COVID-19大流行给药学领域未来发展带来的挑战。更多还原

【Abstract】 Since the outbreak of coronavirus disease 2019(COVID-19) in 2019,it has brought many great changes and impacts on the global pharmaceutical work scene, practitioners, work methods and business scope, among which many changes are related to the future development of global pharmacy and the adjustment of health policies.The International Pharmaceutical Federation(FIP) has been paying attention to the changes in the pharmaceutical field caused by the COVID-19 pandemic, analyzing emerging trends, gaining insight into the opportunities and jointly coping with the challenges to be faced.This article reviews the trend analysis of FIP on the COVID-19 pandemic.Combined with China’s national conditions, the global pharmaceutical development and trends are discussed and judged from the aspects of pharmaceutical practice, pharmaceutical research and pharmaceutical education, in order to cope with the challenges brought by the COVID-19 pandemic to the future development of the pharmaceutical field.更多还原